Raymond James Financial Services Advisors’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,559
| Closed | -$125K | – | 3333 |
|
|
2022
Q1 | $125K | Sell |
6,559
-118
| -2% | -$2.25K | ﹤0.01% | 3057 |
|
|
2021
Q4 | $119K | Sell |
6,677
-343
| -5% | -$6.11K | ﹤0.01% | 3082 |
|
|
2021
Q3 | $260K | Buy |
7,020
+325
| +5% | +$12K | ﹤0.01% | 2785 |
|
|
2021
Q2 | $398K | Buy |
6,695
+180
| +3% | +$10.7K | ﹤0.01% | 2527 |
|
|
2021
Q1 | $437K | Sell |
6,515
-59
| -0.9% | -$3.96K | ﹤0.01% | 2383 |
|
|
2020
Q4 | $398K | Sell |
6,574
-1,849
| -22% | -$112K | ﹤0.01% | 2280 |
|
|
2020
Q3 | $665K | Buy |
8,423
+432
| +5% | +$34.1K | ﹤0.01% | 1798 |
|
|
2020
Q2 | $499K | Buy |
+7,991
| New | +$499K | ﹤0.01% | 1922 |
|
|
2020
Q1 | – | Sell |
-7,327
| Closed | -$887K | – | 2784 |
|
|
2019
Q4 | $887K | Sell |
7,327
-590
| -7% | -$71.4K | ﹤0.01% | 1608 |
|
|
2019
Q3 | $1.44M | Buy |
7,917
+1,525
| +24% | +$277K | 0.01% | 1276 |
|
|
2019
Q2 | $831K | Buy |
6,392
+1,638
| +34% | +$213K | ﹤0.01% | 1602 |
|
|
2019
Q1 | $1.16M | Buy |
4,754
+228
| +5% | +$55.5K | ﹤0.01% | 1371 |
|
|
2018
Q4 | $862K | Buy |
4,526
+16
| +0.4% | +$3.05K | ﹤0.01% | 1342 |
|
|
2018
Q3 | $1.48M | Buy |
4,510
+240
| +6% | +$78.7K | 0.01% | 1231 |
|
|
2018
Q2 | $1.33M | Buy |
4,270
+669
| +19% | +$209K | 0.01% | 1248 |
|
|
2018
Q1 | $877K | Buy |
3,601
+74
| +2% | +$18K | 0.01% | 1383 |
|
|
2017
Q4 | $1.07M | Buy |
3,527
+668
| +23% | +$202K | 0.01% | 1259 |
|
|
2017
Q3 | $756K | Buy |
2,859
+601
| +27% | +$159K | ﹤0.01% | 1483 |
|
|
2017
Q2 | $595K | Buy |
2,258
+1,683
| +293% | +$443K | ﹤0.01% | 1582 |
|
|
2017
Q1 | $207K | Buy |
575
+207
| +56% | +$74.5K | ﹤0.01% | 2116 |
|
|
2016
Q4 | $106K | Buy |
+368
| New | +$106K | ﹤0.01% | 2178 |
|